Summary:
A 26 week study to compare the efficacy of a new formulation of insulin in terms of change in HbA1c in patients with type 1 diabetes.
Qualified Participants Must:
• 18 years of age or older
•
Be on a stable insulin dose for 30 days
•
Have been on basal plus mealtime insulin for at least one year
Qualified Participants May Receive:
Study visits, supplies, study medication at no cost and compensation for timeand travel.